UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

April 28, 2020

Date of Report

(Date of earliest event reported)

 

OZOP SURGICAL CORP.

(Exact name of registrant as specified in its charter)

 

 

Nevada   000-55976   35-2540672
(State or other jurisdiction of Incorporation)  

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

31 Sandfort Ln., Warwick NY 10990

(Address of principal executive offices, including zip code)

 

(845) 544-5112

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

[  ] Written communications pursuant to Rule 425 under the Securities Act
   
[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
   
[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
   
[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
N/A   N/A   N/A

 

 

 

 
 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On April 28, 2020, Brian Conway was appointed to the Company’s Board of Directors. That same day Michael Chermak submitted to the Board of Directors his resignation as a Director of the Company, effective that same day. A copy of Mr. Chermak’s resignation letter is attached as exhibit 99.1 to this Current Report.

 

Brian P. Conway, is the sole officer and director of the Company and brings twenty years of proven success in marketing and business development for both private and publicly traded companies. Starting off in database management and sales for Venture Direct on Madison Avenue, he crossed over to Wall Street first as a co-founder of Waypoint Capital Partners. During this time, he has overseen national sales, marketing, business and product development, national account customers, and new business relations with international and US companies while creating awareness for public companies with many of the nation’s top public relations firms. From October 1, 2014, through August 31, 2019, Mr. Conway was the CEO, CFO and Director of Ngen Technologies, Inc. (f/k/a/ Liberated Solutions, Inc.). His relationships and experience with investment bankers, non-dilutive financing, and public relations should be instrumental in moving the Company forward in the upcoming months.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

  99.1 Resignation letter of Michael Chermak dated April 28, 2020.

 

- 2 -
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: April 29, 2020

 

  OZOP SURGICAL CORP.
   
  By: /s/ Brian Conway
  Name: Brian Conway
  Title: Chief Executive Officer

 

- 3 -

 

Ozop Surgical (PK) (USOTC:OZSC)
Historical Stock Chart
From Jun 2020 to Jul 2020 Click Here for more Ozop Surgical (PK) Charts.
Ozop Surgical (PK) (USOTC:OZSC)
Historical Stock Chart
From Jul 2019 to Jul 2020 Click Here for more Ozop Surgical (PK) Charts.